Michael Petusky, an analyst from Barrington, maintained the Buy rating on Haemonetics (HAE – Research Report). The associated price target remains the same with $108.00. Michael Petusky has given his
Michael Petusky, an analyst from Barrington, maintained the Buy rating on Haemonetics (HAE – Research Report). The associated price target remains the same with $108.00. Michael Petusky has given his
Mizuho Securities analyst Anthony Petrone has maintained their bullish stance on HAE stock, giving a Buy rating today. Anthony Petrone has given his Buy rating due to a combination of
Raymond James analyst Andrew Cooper upgraded Haemonetics (HAE) to Strong Buy from Outperform with an unchanged price target of $120. The firm says that despite the 11% rally to the
אנליסט ב-Raymond James, אנדרו קופר, שדרג את Haemonetics (HAE) ל”קנייה חזקה”, תוך שמירה על מחיר היעד של 120 דולר. הפירמה מציינת כי גם לאחר עלייה של 11% בעקבות תוצאות הרבעון
David Turkaly, an analyst from JMP Securities, reiterated the Buy rating on Haemonetics (HAE – Research Report). The associated price target remains the same with $125.00. David Turkaly has given